Induction of autophagy protects human dental pulp cells from lipopolysaccharide-induced pyroptotic cell death

Abstract

The NOD-like receptor protein 3/caspase-1 inflammasome can be activated in human dental pulp tissue and fibroblasts; however, the underlying mechanisms are poorly understood. In the present study, lipopolysaccharide (LPS) was used to treat dental pulp cells to establish an inflammation model. Cell viability was examined by sulforhodamine B assay. Interleukin (IL)-1β, caspase-1, microtubule-associated protein-1 light chain 3-II/I and p62 were determined by western blotting and ELISA. The phosphorylation (p-) levels of NF-κB and NF-κB inhibitor (IκB)α protein were observed by western blotting. The results demonstrated that LPS induced pyroptotic cell death in cultured dental pulp cells, which was supported by the increased levels of IL-1β, IL-18 and caspase-1. Rapamycin and 3-methyladenine (3-MA) were used to activate and inhibit autophagy, and it was observed that LPS increased autophagy and rapamycin reduced LPS-induced dental pulp cell pyroptosis. However, 3-MA aggravated LPS-induced dental pulp cell pyroptosis. In addition, LPS inhibited the expression of IκBα, but increased the expression of p-NF-κB. Compared with the LPS group, 3-MA further inhibited the expression of IκBα but promoted the expression of p-NF-κB. However, rapamycin produced the opposite results to LPS. Under LPS treatment, the NF-κB pathway inhibitor BAY11-7082 further enhanced the inhibitory effects of rapamycin, but inhibited the promoting effects of 3-MA on the protein expression levels of IL-1β and caspase-1. The results of the present study demonstrated that there is an important crosstalk between autophagy, pyroptosis and the NF-κB pathway, and that the modulation of pyroptosis in dental pulp cells may be a promising strategy to pulpitis therapy.

Introduction

Caries bacteria are a major cause of dental pulpal inflammation and infection (1), and the dental pulp is surrounded by a rigid physical barrier that resists pathogenic challenges (2). The integrity of the barrier undergoes inevitable and irreversible changes due to adverse conditions such as aging, and the caries bacteria and their products penetrate into the pulp tissue if the integrity of the barrier is damaged (2). Gram-negative anaerobic bacteria become dominant in the microflora as carious infection progresses to the pulp-dentin interface (3). Lipopolysaccharide (LPS), the major cell wall component of gram-negative bacteria, is widely used as a pathogen-associated molecule to mimic clinical pathological conditions (4,5). Studies have increasingly demonstrated that cell death is caused by apoptosis, necrosis or pyroptosis, which can be induced by inflammation (6,7). These findings suggest that bacterial infections may trigger an inflammatory response that can lead to cell death.

Pyroptosis, often referred to as inflammatory cell death, induces the release of inflammatory cytokines interleukin (IL) 1β and IL-18 by activating inflammatory complexes composed of caspase-1 (8). NOD-like receptor protein 3 (NLRP3) inflammasome-mediated caspase-1 activation and the subsequent secretion of pro-inflammatory cytokines including IL-1β and IL-18 are markers for pyroptosis (9). NLRP3 inflammasome has been reported to be expressed in dental pulp tissue (10). However, whether the NLRP3 inflammasome/caspase-1/IL-1β/IL-18 signaling pathway in dental pulp cells is activated during dental pulp inflammation has not yet been investigated to the best of the authors' knowledge. The NF-κB family of inducible transcription factors serve an essential role in different aspects of immune responses (11). A previous study has demonstrated that the activation of NF-κB may promote the transcriptional expression of inflammatory factors (12). The major NF-κB inhibitor (IκB) family member that regulates the classical NF-κB pathway is IκBα, which is characterized by its dynamic changes and signal-induced NF-κB activation (11). Thus, targeting the NF-κB pathway may be an effective therapy for dental pulpal inflammation.

As a highly conserved catabolic pathway, autophagy is involved in multiple pathological conditions and in numerous physiological processes including cell death (13) and differentiation (14), neurodegeneration (15), immunity (16) and organ development (17,18). Previous studies have also revealed that autophagy participates in odontoblast aging (19) and tooth development (20). Autophagy is usually accompanied by changes in microtubule-associated protein 1 light chain 3 (LC3) α and p62 (21,22). Autophagy exerts protective roles in the early stage of inflamed odontoblasts, whereas the over-induction of autophagy leads to odontoblast cell death (23). LPS can stimulate autophagy in endothelial cells, cardiomyocytes and macrophages (24–26); however, the effects of autophagy on LPS-induced cytotoxicity and whether autophagy in dental pulp cells could be activated by LPS have yet to be investigated.

The present study hypothesized that LPS induced NLRP3/caspase-1-dependent pyroptosis in dental pulp cells, which may be inhibited by autophagy and the NF-κB signaling pathway. Therefore, the aims of the present study were to: i) Investigate whether pyroptosis in dental pulp cells was activated in response to LPS; and ii) elucidate the effects of autophagy during the process and determine if the NF-κB signal pathway was involved.

Materials and methods

Cell isolation, culture and identification

As described previously (27), human dental pulp cells were isolated from intact, caries-free supernumerary teeth that had been freshly extracted from six healthy children aged between 7 and 10 years old. The study protocol was approved by the Ethical Committee of Nanjing Medical University (approval no. NM20180510). Written informed consent was obtained from the children's parents or legal representatives. The teeth were maintained in phosphate buffer saline (PBS) and split open following extraction. Under sterile conditions, the dental pulp tissues were removed and minced using a surgical knife, transferred to a centrifuge tube and centrifuged at 300 × g for 5 min at room temperature. The supernatant was removed and the sample was incubated at 37°C for 45 min with type I collagen and centrifuged again at 300 × g for 5 min at room temperature. Following removal of the supernatant, the sample was washed three times with α-MEM medium (Gibco; Thermo Fisher Scientific, Inc.) containing 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.) and centrifuged at 300 × g for 5 min at room temperature. The obtained cells were suspended in a-MEM medium containing 20% FBS, seeded in cell culture bottles and incubated at 37°C with 5% CO₂.

Dental pulp cells at the logarithmic growth phase at the third passage were washed with PBS twice and digested with PBS containing 0.25% trypsin for single-cell suspension preparation. The cell suspension (100 µl) was added to an Eppendorf tube (3×10⁹ cells/tube) and incubated with rat-anti-human monoclonal antibodies CD29-PE (cat. no. bs-0486R-PE; 1:100), CD105-PE (cat. no. bs-0579R-PE; 1:100), CD146-PE (cat. no. bs-1618R-PE; 1:100), CD34-PE (cat. no. bs-0646R-PE; 1:100), CD45-PE (cat. no. bs-0522R-PE; 1:100), CD90-PE (cat. no. bs-0778R-PE; 1:100; all from Bioss Biotechnology Co., Ltd.) and rat-anti-human STRO-1 (cat. no. ab214086; 1:500; Abcam) at 4°C for 30 min, followed by incubation for 15 min in the dark, washing with PBS, centrifugation at 300 × g for 5 min at room temperature, suspension and fixation with PBS containing 1% paraformaldehyde. Background markers were identified using homotype controlled monoclonal antibodies. Flow cytometry (Becton, Dickinson and Company) and FlowJo software version 7.6.2 (FlowJo LLC) were used to analyze the cells. According to the results, the cells with the best purity, defined as the highest positive cell surface antigen rate, were selected for subsequent experiments.

Pure dental pulp cells at passages 3 to 4 were used for drug treatment. Briefly, different concentration of LPS (0, 10, 100, 200, 300, 500 and 1,000 µg/l), rapamycin (2 µM), 3-methyladenine (3-MA; 10 mM) and BAY11-7082 (2.5 µM; all from Sigma-Aldrich; Merck KGaA) were used to pretreat the dental pulp cells for 72 h.

Western blot analysis

Western blot analysis was conducted as previously described (28). The total protein was extracted from human dental pulp cells (2×10⁶) using RIPA lysis buffer containing Halt Protease and Phosphatase Inhibitor Cocktail (Pierce; Thermo Fisher Scientific, Inc.). Bicinchoninic acid protein assay kit (Pierce; Thermo Fisher Scientific, Inc.) was applied to determine the protein concentration. Proteins (30 µg/lane) were separated by SDS-PAGE (10% gel) and transferred to a PVDF membrane (Bio-Rad Laboratories, Inc.). The membrane was blocked with 5% skim milk in PBS-Tween-20 for 2 h. Membranes were incubated primary antibodies overnight at 4°C, and with secondary antibodies for 2 h at room temperature. In addition, to detect the protein expression of IL-1β, cell culture media were collected and the proteins in the media were precipitated using trichloroacetic acid protein precipitation method as previously described (29). The band signal was developed using an Enhanced Chemiluminescence kit (Beyotime Institute of Biotechnology) and exposed to X-ray film. The relative quantity of proteins was determined by Image J (version 1.47; National Institutes of Health) and normalized to loading controls. The antibodies used were as follows: Anti-β-tubulin (50 kDa; rabbit; 1:1,000; cat. no. ab6046; Abcam), anti-IL-1β (17 kDa; rabbit; 1:1,000; cat. no. 12703; Cell Signaling Technology, Inc.), anti-pro-IL-1β (17 kDa; rabbit; 1:1,000; cat. no. 83186; Cell Signaling Technology, Inc.), anti-caspase-1 (45 kDa; rabbit; 1:1,000; cat. no. ab74279; Abcam), anti-pro-caspase-1 (20/22 kDa; rabbit; 1:1,000; cat. no. 4199; Cell Signaling Technology, Inc.), anti-phosphorylated (p-)NF-κB (65 kDa; rabbit; 1:1,000; cat. no. 3039; Cell Signaling Technology, Inc.), anti-NF-κB (65 kDa; rabbit; 1:1,000; cat. no. 8242; Cell Signaling Technology, Inc.), anti-IκBα (36 kDa; rabbit; 1:1,000; cat. no. ab32518; Abcam), anti-p62 (62 kDa; mouse; 1:1,000; cat. no. ab56416; Abcam) and anti-LC3-II/LC3-I (~16 and ~18 kDa; rabbit; 1:1,000; cat. no. ab51520; Abcam), and the secondary antibodies were horseradish peroxidase-conjugated goat anti-mouse/rabbit IgG (1:2,000; sc-516102/ sc-2357; Santa Cruz Biotechnology, Inc.).

ELISA

The cultured supernatant IL-18 content was determined by ELISA using a human IL-18 kit (cat. no. SEA064Hu; USCN Life Sciences, Inc.). The assay was performed according to the manufacturer's instructions and the results were calculated relative to standard curves prepared for IL-18.

Cell viability

Cell viability was determined by sulforhodamine B (SRB) assay (cat. no. 230162, Sigma-Aldrich; Merck KGaA). Briefly, the dental pulp cells were seeded in 96-well plates at a density 1×10⁶ cells/ml and cultured to ~70–80% confluence. Next, the cells were fixed with 50% trichloroacetic acid at 4°C for 1 h and stained by 0.4% SRB solution for 30 min at room temperature. SRB was measured as the absorbance at 565 nm using a Bio-Rad microplate reader (Bio-Rad Laboratories, Inc.).

Statistical analysis

Data are presented as the mean ± SEM. GraphPad Prism 7 (GraphPad Software, Inc.) was used for statistical analysis. Statistical comparisons between two and among multiple groups were performed using Student's t-test and one-way analysis of variance followed by Dunnett's test, respectively. P<0.05 was considered to indicate a statistically significant difference.

Results

Pyroptotic cell death is induced by LPS in cultured dental pulp cells

Human dental pulp cells were examined by flow cytometry, and the results demonstrated that these cells were positive for CD29, CD90, CD105, CD146 and STRO-1, but negative for the cell surface antigens CD34 and CD45 (Fig. 1A). These surface antigens were consistent with those expressed on dental pulp cells in a previous study (30), indicating that human dental pulp cells were successfully cultured and isolated in the current study. The effect of LPS stimulation on dental pulp cells were investigated by SRB assay after treating the cells with different concentrations of LPS for 72 h; the results demonstrated that LPS reduced cell viability in a concentration-dependent manner (Fig. 1B). When the cells were treated with 300 µg/l LPS, cell viability significantly decreased (P<0.01); thus 300 µg/l LPS was selected for subsequent experiments. A significant decrease in dental pulp cell viability was observed in the LPS group at 72 h compared with the control group (Fig. 1C). The secretion levels of the pyroptosis markers IL-1β and IL-18 and caspase-1 activation were assessed by western blotting and ELISA following LPS treatment for 24, 48 and 72 h. Western blot assay results demonstrated that LPS upregulated the protein levels of extracellular IL-1β (Fig. 1D) and caspase-1 (Fig. 1E) in a time-dependent manner without affecting the accumulation of pro-IL-1β (Fig. 1F) and pro-caspase-1 (Fig. 1G) in the dental pulp cells (Fig. 1H). Similarly, ELISA assay data demonstrated that LPS increased the extracellular content of IL-18 at 48 and 72 h (Fig. 1I). These results demonstrated that LPS increased the extracellular secretion of IL-1β and IL-18 and caspase-1 activation, suggesting that LPS may induce pyroptotic cell death in cultured dental pulp cells. Based on these results, 72 h was selected as the treatment duration for the following experiments.

Figure 1.

Pyroptotic cell death is induced by LPS in cultured dental pulp cells. (A) Human dental pulp cell surface marker expression was examined using flow cytometry. (B) Effects of different concentrations of LPS (0, 10, 100, 200, 300, 500 and 1,000 µg/l) on human dental pulp cell viability. (C) Human dental pulp cell viability was inhibited by LPS as determined by sulforhodamine B assay. (D and E) The protein levels of (D) IL-1β and (E) caspase-1 were normalized to that of β-tubulin. (F and G) The protein levels of (F) (pro)-IL-1β and (G) (pro)-caspase-1 were normalized to that of β-tubulin. (H) Western blot assay was used to detect the contents of IL-1β, caspase-1, pro-IL-1β and pro-caspase-1. (I) IL-18 contents were determined by ELISA. *P<0.05 and **P<0.01 vs. control; ^##P<0.01 vs. 48 h. LPS, lipopolysaccharide; IL, interleukin.

Autophagy is activated by LPS

To study the effect of LPS stimulation on dental pulp cell autophagy and whether chemical modulators of autophagy may regulate the autophagy of dental pulp cells under LPS treatment, the protein levels of autophagy markers LC3 and p62 were determined by western blotting (Fig. 2A). The results revealed that under LPS stimulation, the ratio of LC3-II/LC3-I protein levels was increased with notable upregulation of LC3-II compared with the control group (Fig. 2B and C); however, p62 accumulation was slightly decreased (Fig. 2A and D). In addition, the LC3-II/LC3-I ratio was increased and LC3-II content and p62 were further upregulated by rapamycin treatment, whereas 3-MA treatment produced opposite effects to rapamycin (Fig. 2), indicating that rapamycin induced autophagy, whereas 3-MA inhibited autophagy in dental pulp cells under LPS treatment.

Figure 2.

Autophagy is activated by LPS. (A) Western blot analysis of autophagy-related proteins LC3 and p62. (B) The LC3-II/LC3-I ratio was determined based on densitometric analysis of the bands shown in (A). (C) LC3-II protein level was quantified based on densitometry analysis of bands shown in (A). (D) The P62 protein level was quantified based on densitometry analysis of bands shown in (A). *P<0.05 and **P<0.01 vs. control; ^#P<0.05 and ^##P<0.01 vs. LPS. LPS, lipopolysaccharide; LC3, microtubule-associated protein 1 light chain 3; Rapa, rapamycin; 3-MA, 3-methyladenine.

LPS-induced pyroptotic cell death is suppressed by autophagy

Autophagy is activated by LPS; however, its role in pyroptotic cell death is unclear. Therefore, the effects of rapamycin and 3-MA on pyroptotic cell death and the viability of dental pulp cells were investigated under LPS treatment. Pyroptotic characteristics such as IL-1β (Fig. 3A and B) and IL-18 secretion (Fig. 3F), as well as caspase-1 activation (Fig. 3A and C) in the LPS group were significantly inhibited by rapamycin, but enhanced by 3-MA without affecting the levels of pro-IL-1β (Fig. 3A and D) and pro-caspase-1 (Fig. 3A and E). Consistently, SRB assay results demonstrated that rapamycin treatment significantly attenuated the LPS-induced decrease in dental pulp cell viability, whereas 3-MA pretreatment exerted an opposite effect (Fig. 3G).

Figure 3.

LPS-induced pyroptotic cell death is suppressed by autophagy. (A) Western blot assay was used to detect the contents of (pro)-IL-1β and (pro)-caspase-1. (B and C) The protein levels of (B) IL-1β and (C) caspase-1 were normalized to that of β-tubulin. (D and E) The protein levels of (D) pro-IL-1β and (E) pro-caspase-1 were normalized to that of β-tubulin. (F) IL-18 contents were determined by ELISA. (G) Human dental pulp cell viability was inhibited by LPS as revealed by sulforhodamine B assay. *P<0.05 and **P<0.01 vs. control; ^#P<0.05 and ^##P<0.01 vs. LPS. LPS, lipopolysaccharide; IL, interleukin; Rapa, rapamycin; 3-MA, 3-methyladenine.

Autophagy inhibits LPS-induced pyroptotic death of dental pulp cells by regulating the NF-κB signaling pathway

To detect whether autophagy inhibited LPS-induced pyroptotic dental pulp cell death by regulating the NF-κB signaling pathway, the levels of p-NF-κB, NF-κB and IκBα were determined by western blot assay, and the NF-κB signaling pathway inhibitor BAY11-7082 was used. Under LPS stimulation, the protein level of p-NF-κB was significantly upregulated, whereas that of IκBα was downregulated in dental pulp cells compared with that in the control group, and this effect was further enhanced by 3-MA, but weakened by rapamycin (Fig. 4A and B). No significant difference was observed in the expression of NF-κB among all groups. Under BAY11-7082 and LPS treatment, there was an evident decrease in the elevated IL-1β and caspase-1 activation induced by LPS. Of note, rapamycin inhibited the elevation of IL-1β and caspase-1 activation induced by LPS, and these inhibitory effects were further enhanced by BAY11-7082 (Fig. 4C-E). 3-MA promoted LPS-induced IL-1β elevation and caspase-1 activation, which was partially reversed by BAY11-7082 (Fig. 4C-E). In addition, the results demonstrated that BAY11-7082 partially reversed the decreased dental pulp cell viability induced by LPS; BAY11-7082 further increased the promoting effects of rapamycin on dental pulp cell viability, but attenuated the inhibitory effect of 3-MA on cell viability (Fig. 4F).

Figure 4.

Autophagy inhibits LPS-induced pyrolytic dental pulp cell death by regulating the NF-κB signaling pathway. (A) Western blot assay was used to detect the contents of p-NF-κB, NF-κB and IκBα. (B) The protein levels of p-NF-κB, NF-κB and IκBα were quantified and normalized to that of β-tubulin. (C and D) The levels of (C) IL-1β and (D) caspase-1 were quantified and normalized to that of β-tubulin. (E) Western blot assay was used to detect IL-1β and caspase-1. (F) Human dental pulp cell viability was detected using sulforhodamine B assay. **P<0.01 vs. control; ^#P<0.05 and ^##P<0.01 vs. LPS; ^{^}P<0.05 and ^{^^}P<0.01 vs. LPS+Rapa; ^$$P<0.01 vs. LPS+3-MA. LPS, lipopolysaccharide; p-, phosphorylated; IκB, NF-κB inhibitor; IL, interleukin; Rapa, rapamycin. 3-MA, 3-methyladenine.

Discussion

The present study investigated the role of pyroptotic cell death in inflamed dental pulp cells. The results demonstrated that LPS induced pyroptotic cell death in cultured dental pulp cells; this was inhibited by autophagy induction. In addition, autophagy was increased to a certain extent under LPS treatment, suggesting that the activation of autophagy may be a self-help measure in inflamed dental pulp cells, and the activation was enhanced by rapamycin-induced autophagy. Thus, it was hypothesized that rapamycin may be regarded as a potential drug candidate for inducing autophagy, which is likely to inhibit LPS-induced pyroptotic cell death in cultured dental pulp cells. The LPS-activated p-NF-κB/IκBα signaling pathway was inhibited by rapamycin-induced autophagy, whereas 3-MA-inhibited autophagy produced effects opposite to those of LPS.

Dental pulp cells are the primary targets for inflammatory agents, and the mechanism underlying dental pulp cell fate determination in an inflammatory microenvironment needs to be studied to protect dental pulp cells. To determine whether LPS-stimulated dental pulp cells induced inflammation, it was identified that pyroptosis-induced pro-inflammatory cytokines IL-1β and caspsase1 (18,31,32) increased significantly as LPS treatment time increased, suggesting that LPS-stimulated dental pulp cells could mimic the pyroptotic death of dental pulp cells; these were therefore used as a model for exploring the mechanism of pyroptotic dental cell death. Apoptosis-associated speck like protein (ASC) and NLRP3 are involved in the activation of caspase-1 (33,34). Jiang et al (10) have reported that the NLRP3/caspase-1 pathway exhibits a biological role in the innate immune response mounted by human dental pulp fibroblasts. In the present study, LPS activated caspase-1 in dental pulp cells, which is associated with the formation of NLRP3 inflammatory corpuscles (3). Further activation of the inflammasome induces pyroptosis (35). However, in present study, the expression of NLRP3 and ASC were not examined; this is a limitation and requires further study.

Several studies have determined the expression levels of autophagy molecules in aging human odontoblast and dental pulp cells (36–39). It has been reported that autophagy induction serves a protective role against hypoxic stress in human dental pulp cells (40). Increased levels of autophagy molecules including ATG5, LC3-II and Beclin-1 have been identified in adult human dental pulp, especially in aged pulp cells (41). Under LPS stimulation, autophagy-related molecules are differentially expressed in adult pulp tissue and aged human dental pulp cells (39). In the current study, the ratio of LC3-II/LC3-I was increased following LPS treatment. Autophagy agonist rapamycin further increased the ratio of LC3-II/LC3-I, whereas the inhibition of autophagy by 3-MA reversed these effects. The results also demonstrated that rapamycin inhibited the elevation of IL-1β, caspase-1 and IL-18 following LPS stimulation, whereas 3-MA generated opposite effects to those of LPS. These results demonstrated that autophagy was activated in LPS-treated dental pulp cells and that targeting autophagy may be an effective therapy for dental pulpal inflammation.

NF-κB is an important transcription factor that regulates inflammation and is a part of an essential signaling pathway involved in the LPS-induced expression of cytokines (42). Previous studies have demonstrated that autophagy is required for the activation of NF-κB (43), and that NF-κB negatively regulates autophagy in specific cell types in vitro, including RAW 264.7 cells and bone marrow-derived macrophages upon brief coculture with E. coli (44). A previous study has suggested that rapamycin may suppress the generation of IL-1β and IL-18 in LPS-treated RAW264.7 cells by decreasing NF-κB signaling and increasing autophagy (45). In the present study, the NF-κB/IκBα signaling pathway was activated by LPS. The effects of 3-MA and rapamycin on the expression levels of IκBα and p-NF-κB were reversed by BAY11-7082, which is an NF-κB pathway inhibitor. These results demonstrated that autophagy may inhibit the LPS-induced pyrolysis death of dental pulp cells by regulating the NF-κB signaling pathway.

Rapamycin affects cell cycle, proliferation, autophagy and protein synthesis by suppressing mammalian target of rapamycin (mTOR) activity (46,47). Previous studies have demonstrated that mTOR signaling serves a key role in mediating chronic inflammation and is involved in regulating inflammatory factors, including IL-1β and TNF-α (48,49). Rapamycin-induced inhibition of mTOR has been reported to significantly reduce the inflammation induced by various substances (50,51). Previous studies have demonstrated that rapamycin exhibits anti-inflammatory actions by affecting NF-κB activity (52,53). In the current study, rapamycin induced autophagy by regulating autophagy-related genes, such as LC3-II and p62. Rapamycin may inhibit the LPS-induced pyroptotic cell death by inhibiting the expression of IL-1β and regulating the NF-κB/IκBα signaling pathway.

However, the current study had certain limitations. For example, the effect of rapamycin-induced autophagy on LPS-mediated dental pulp cell pyroptosis was not verified in vivo. In addition, the present study was conducted on dental pulp cells from healthy teeth without comorbidities common in teeth susceptible to caries infection. Although the aim of the current study was to explore whether rapamycin-induced autophagy may produce protective effects against LPS-mediated dental pulp cell pyroptosis, the safety and efficacy of rapamycin in clinical treatment still requires further investigation. Based on the current experimental design, it is difficult to exclude the direct protective effect of rapamycin-induced autophagy independent of pyroptosis. Autophagy may be one of several relevant secondary effects of mTOR inhibition, and the role of rapamycin in this system needs to be further studied. In addition, the current study only compared the effects of LPS on cells with the baseline, but not with controls incubated with medium over equivalent time. Finally, the photomicrographs of the LPS treated cells were not presented.

In conclusion, the present study demonstrated that LPS treatment may induce a low level of autophagy, which may be a self-help strategy in dental pulp cells. These results highlighted for the first time the potential of rapamycin in pulpitis therapy.

Funding

This work was supported by Jiangsu Provincial Key Research Development Program (Social Development) (grant no. BE2016796).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

YG and XY made substantial contributions to conception and design; YL, FG, JY, CY and YZ were responsible for data acquisition, analysis and interpretation; and JY and CY drafted the article or critically revising it for important intellectual content. All authors agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of the work are appropriately investigated and resolved and all authors gave final approval of the version to be published.

Ethics approval and consent to participate

The study protocol was approved by the Ethical Committee Department of Nanjing Medical University (cat. no: NM20180510). Written informed consents were obtained from the children's parents or legal representatives. All procedures involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.